![](/img/cover-not-exists.png)
87. The use of the newly developed synthetic TLR-4 agonistas an immuno-therapeutic agent in a cancer model
Matzner, P., Shaashua, L., Sorski, L., Levi, B., Melamed, R., Rosenne, E., Benbenishty, A., Horowitz, M., Ben-Eliyahu, S.Volume:
32
Language:
english
Journal:
Brain, Behavior, and Immunity
DOI:
10.1016/j.bbi.2013.07.099
Date:
September, 2013
File:
PDF, 39 KB
english, 2013